Tema Heart & Health ETF (HRTS)
NasdaqGM: HRTS
· Цена в реальном времени · USD
38.84
+1.51 (4.05%)
На закрытии: Aug 18, 2026, 3:25 PM
Tema Heart & Health ETF (HRTS) ETF Price, Holdings & Analysis
4.05% (1D)
| Покупка | 26.28 |
| Рыночная капитализация | n/a |
| AUM | 54.27M |
| NAV | 37.28 |
| Бета | н/д |
| EPS (TTM) | н/д |
| P/E (TTM) | 26.41 |
| Акций в обращении | н/д |
| Дата запуска | Nov 20, 2023 |
| Продажа | 47.47 |
| Объём | 3,549 |
| Сред. объём (20Д) | 5,819 |
| Открытие | 37.74 |
| Пред. закрытие | 37.33 |
| Диапазон дня | 37.70 - 37.86 |
| Диапазон за 52 недели | 29.02 - 37.86 |
| Активы | н/д |
| Коэффициент расходов | 0.75% |
О HRTS
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from products or services related to GLP-1 and the treatment of cardiovascular diseases and/or metabolic diseases, as defined by the Centers for Diseases Control and Preventions. The fund generally is expected to consist of more than 15 companies but not more than 100 companies. The fund is non-diversified.
Класс активов Equity
Тикер HRTS
Дата запуска Nov 20, 2023
Управляющая компания Tema Etfs
Сайт Страница фонда
Биржа NasdaqGM
Топ-10 активов 48.89% активов
| Название | Тикер | Вес |
|---|---|---|
| Eli Lilly And Co | LLY | 11.32% |
| Unitedhealth Group I... | UNH | 5.50% |
| Novo Nordisk As Clas... | NOVO-B.CO | 5.12% |
| Thermo Fisher Scient... | TMO | 4.54% |
| Roche Holding Ag Adr | RHHBY | 4.18% |
| Merck & Co Inc | MRK | 4.16% |
| Johnson & Johnson | JNJ | 3.86% |
| Astrazeneca PLC | AZN.L | 3.46% |
| Revolution Medicines... | RVMD | 3.44% |
| Novartis Ag Register... | NOVN.SW | 3.31% |
Дивиденды Дивидендная доходность 2.43%
| Дата отсечки | Сумма | Дата выплаты |
|---|---|---|
| Dec 10, 2025 | $0.4730 | н/д |
| Dec 11, 2024 | $0.4690 | н/д |
